Table 2.

Frequency of adverse events by time since vaccination

	0–30 min		31 min to 3 days		4–14 days		Overall (0–14 days)
	Response rate	Frequency	Response rate	Frequency	Response rate	Frequency	Response rate	Frequency
Adults (≥18 years, n=1207)
Arthralgia	100%	0	97%	80 (7%)	96%	1 (<1%)	93%	81 (7%)
Diarrhoea	100%	0	97%	3 (<1%)	96%	0	93%	3 (<1%)
Fatigue	100%	1 (<1%)	97%	118 (10%)	96%	1 (<1%)	94%	119 (10%)
Fever	100%	0	97%	1 (<1%)	96%	0	93%	1 (<1%)
Headache	100%	0	97%	180 (15%)	96%	0	94%	180 (16%)
Induration	100%	0	97%	1 (<1%)	96%	0	93%	1 (<1%)
Injection pain	100%	1 (<1%)	97%	37 (3%)	96%	0	93%	38 (3%)
Muscle pain	100%	0	97%	157 (13%)	96%	0	94%	157 (14%)
Myalgia	100%	0	97%	149 (13%)	96%	0	94%	149 (13%)
Vomiting	100%	0	97%	2 (<1%)	96%	0	93%	2 (<1%)
Other adverse events	100%	2 (<1%)	97%	29 (2%)	96%	2 (<1%)	93%	33 (3%)
Any adverse events*	100%	3 (<1%)	97%	408 (35%)	96%	4 (<1%)	94%	412 (36%)
Children (6–17 years, n=303)
Arthralgia	100%	0	94%	1 (<1%)	>99%	0	93%	1 (<1%)
Diarrhoea	100%	0	94%	2 (1%)	>99%	0	93%	2 (1%)
Fatigue	100%	0	94%	3 (1%)	>99%	1 (<1%)	93%	3 (1%)
Fever	100%	0	94%	0	>99%	0	93%	0
Headache	100%	0	94%	33 (12%)	>99%	1 (<1%)	93%	34 (12%)
Induration	100%	0	94%	0	>99%	0	93%	0
Injection pain	100%	0	94%	0	>99%	0	93%	0
Muscle pain	100%	0	94%	10 (4%)	>99%	0	94%	10 (4%)
Myalgia	100%	0	94%	9 (3%)	>99%	0	94%	9 (3%)
Vomiting	100%	0	94%	0	>99%	0	93%	0
Other adverse events	100%	0	94%	3 (1%)	>99%	1 (<1%)	93%	4 (1%)
Any adverse events*	100%	0	94%	47 (17%)	>99%	2 (1%)	94%	47 (17%)

Data are % or n (%). Response rates were used to calculate the percentage of events for each line.

^*Response rate calculated as the proportion of individuals who answered all adverse event fields or reported at least one adverse events.